- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2497EUR$2,789USD£2,181GBP
- Report
- January 2026
- 185 Pages
Global
From €3173EUR$3,545USD£2,772GBP
€3526EUR$3,939USD£3,080GBP
- Report
- April 2026
- 386 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- February 2026
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- January 2026
- 450 Pages
Global
From €4476EUR$5,000USD£3,909GBP
- Report
- January 2026
- 220 Pages
Global
From €2238EUR$2,500USD£1,955GBP
- Report
- January 2026
- 450 Pages
Global
From €4476EUR$5,000USD£3,909GBP
- Clinical Trials
- July 2025
- 280 Pages
Global
From €2685EUR$3,000USD£2,346GBP
- Report
- April 2026
- 286 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- March 2026
- 200 Pages
Global
From €2497EUR$2,789USD£2,181GBP
- Report
- June 2025
- 200 Pages
Global
From €2497EUR$2,789USD£2,181GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2497EUR$2,789USD£2,181GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2497EUR$2,789USD£2,181GBP
- Report
- June 2025
- 200 Pages
Global
From €2497EUR$2,789USD£2,181GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2497EUR$2,789USD£2,181GBP
- Report
- April 2023
- 501 Pages
Global
From €4476EUR$5,000USD£3,909GBP
- Report
- June 2024
- 200 Pages
Global
From €7116EUR$7,950USD£6,216GBP
- Report
- June 2024
- 200 Pages
Global
From €7116EUR$7,950USD£6,216GBP
- Report
- June 2024
- 200 Pages
Global
From €7116EUR$7,950USD£6,216GBP
- Report
- June 2024
- 200 Pages
Global
From €7116EUR$7,950USD£6,216GBP

The Tumor Drug market is a subset of the Oncology Drugs market, which focuses on the development and sale of drugs used to treat cancer. These drugs are used to target and destroy cancer cells, reduce the size of tumors, and reduce the spread of cancer. Tumor drugs are typically divided into two categories: cytotoxic drugs, which kill cancer cells, and targeted therapies, which target specific molecules involved in cancer growth. These drugs are often used in combination with other treatments, such as radiation and surgery, to maximize the effectiveness of treatment.
The Tumor Drug market is highly competitive, with many companies developing and selling drugs to treat cancer. Some of the major players in the market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. Other companies, such as AstraZeneca, Eli Lilly, and Amgen, are also active in the market. Show Less Read more